<DOC>
	<DOC>NCT02230956</DOC>
	<brief_summary>This study will evaluate the efficacy and safety of a single intra-articular injection of 2 doses of BOTOX® (onabotulinumtoxinA) compared with placebo as treatment for knee osteoarthritis symptoms.</brief_summary>
	<brief_title>BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Painful osteoarthritis Able to discontinue antiinflammatory drugs and analgesics Must be ambulatory without assistive walking devices Chronic pain conditions other than knee osteoarthritis Treatment with corticosteroids in the study knee within 12 weeks Treatment with hyaluronic acid in the study knee within 24 weeks Previous treatment with any botulinum toxin for any reason Diagnosis of myasthenia gravis, EatonLambert syndrome, or amyotrophic lateral sclerosis</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>